- Home
- SLRX vs SONN Comparison
SLRX vs SONN Comparison
Compare SLRX & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- SONN
- Stock Information
- Founded
- SLRX N/A
- SONN N/A
- Country
- SLRX United States
- SONN United States
- Employees
- SLRX N/A
- SONN N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- SLRX Health Care
- SONN Health Care
- Exchange
- SLRX Nasdaq
- SONN Nasdaq
- Market Cap
- SLRX N/A
- SONN 2.5M
- IPO Year
- SLRX N/A
- SONN N/A
- Fundamental
- Price
- SLRX $0.76
- SONN $1.26
- Analyst Decision
- SLRX
- SONN Strong Buy
- Analyst Count
- SLRX 0
- SONN 2
- Target Price
- SLRX N/A
- SONN $38.00
- AVG Volume (30 Days)
- SLRX 379.2K
- SONN 37.4K
- Earning Date
- SLRX 03-24-2025
- SONN 05-13-2025
- Dividend Yield
- SLRX N/A
- SONN N/A
- EPS Growth
- SLRX N/A
- SONN N/A
- EPS
- SLRX N/A
- SONN N/A
- Revenue
- SLRX N/A
- SONN $1,000,000.00
- Revenue This Year
- SLRX N/A
- SONN N/A
- Revenue Next Year
- SLRX N/A
- SONN N/A
- P/E Ratio
- SLRX N/A
- SONN N/A
- Revenue Growth
- SLRX N/A
- SONN 674.14
- 52 Week Low
- SLRX $0.70
- SONN $1.22
- 52 Week High
- SLRX $7.20
- SONN $16.80
- Technical
- Relative Strength Index (RSI)
- SLRX 32.03
- SONN 39.32
- Support Level
- SLRX $0.69
- SONN $1.33
- Resistance Level
- SLRX $0.94
- SONN $1.35
- Average True Range (ATR)
- SLRX 0.07
- SONN 0.09
- MACD
- SLRX 0.01
- SONN 0.00
- Stochastic Oscillator
- SLRX 13.64
- SONN 34.00
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.